Literature DB >> 17236238

The determination of raloxifene in rat tissue using HPLC.

Zhaoyong Yang1, Xiaobo He, Yueqin Zhang.   

Abstract

We report a rapid and reliable HPLC-UV method for determination of raloxifene, a kind of selective estrogen receptor modulator (SERM), in rat tissue. Proteins were precipitated by adding 200 microL of acetonitrile and 50 microL of methanol to 100 microL of the tissue homogenates, following vortex mixing and centrifugation. Separation was carried out on a reversed-phase C(18) column (150 x 4.6 mm, 5 microm) with a mobile phase of acetonitrile:0.05 m ammonium acetate (pH 4.0 +/- 0.1; 33:67, v/v) at a flow rate of 1.0 mL/min. The UV detection wavelength was set at 289 nm and the temperature of column was kept at 23 degrees C, without interference from endogenous tissue compounds. The calibration curve was linear from 0.0125 to 10.0 microg/mL with correlation coefficient of over 0.994, while the limit of quantification was 0.008 microg/mL. The intra- and inter-day coefficients of variation were less than 10% (RSD). The recovery of assay was between 95.8 and 104.5%. Furthermore, the method was used to measure the concentration of raloxifene in rat tissue after a simple oral dose. The highest level was observed in liver, lung, spleen, then heart and kidney. The lowest level was found in brain. These results suggest that raloxifene distributes rapidly and moderately into tissues such as liver, lung and spleen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236238     DOI: 10.1002/bmc.725

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  6 in total

1.  A titratable two-step transcriptional amplification strategy for targeted gene therapy based on ligand-induced intramolecular folding of a mutant human estrogen receptor.

Authors:  Ian Y Chen; Ramasamy Paulmurugan; Carsten H Nielsen; David S Wang; Vinca Chow; Robert C Robbins; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

2.  Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.

Authors:  Yun Ju Chae; Dae Hun Kim; Hong Joon Lee; Ki-Wug Sung; Oh-Joo Kwon; Sang June Hahn
Journal:  Pflugers Arch       Date:  2014-09-18       Impact factor: 3.657

3.  Tamoxifen and raloxifene modulate gap junction coupling during early phases of retinoic acid-dependent neuronal differentiation of NTera2/D1 cells.

Authors:  Liane Dahm; Fanny Klugmann; Angeles Gonzalez-Algaba; Bernhard Reuss
Journal:  Cell Biol Toxicol       Date:  2010-05-01       Impact factor: 6.691

4.  Systematical approach in evaluation of LC method for determination of raloxifene hydrochloride and its impurities employing experimental design.

Authors:  B Jančić Stojanović; T Rakić; B Slavković; N Kostić; A Vemić; A Malenović
Journal:  J Pharm Anal       Date:  2012-10-07

Review 5.  Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.

Authors:  Leo Veenman
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

6.  Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.

Authors:  Manal A Elsheikh; Yosra S R Elnaggar; Eman Y Gohar; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2012-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.